San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Power Life Sciences Inc. dba Power is raising $6,954,927.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Brandon Li played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Power Life Sciences Inc. dba Power
We believe that every patient deserves the chance to participate in a life changing clinical trial. For patients where the standard treatments have not worked, cutting edge research can present the best hope. Unfortunately, today, most patients are structurally shut out from the clinical trial system. They do not go to academic research hospitals so theyre left struggling to navigate an opaque system littered with medical jargon and middle-men. At the same time, researchers are struggling to recruit patients roughly 86% of all clinical trials are delayed while trying to find enough patients. This is why we built Power. To increase access by empowering all patients. Power is the most patient-friendly platform for clinical trials. We are making it easy for all patients to discover promising clinical trials and get in touch with the researchers directly.

To learn more about Power Life Sciences Inc. dba Power, visit http://www.withpower.com/

Contact:
Brandon Li, Chief Executive Officer
415-900-4227
brandon@withpower.com
https://www.linkedin.com/in/brandonhli/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved